Analysis

Oruka Therapeutics is set to increase its engagement with the investment community through a series of high-profile appearances. The biotechnology...

A significant leadership appointment signals a more aggressive phase for Advanced Micro Devices (AMD) as it seeks to capitalize on...

Following a series of recent acquisitions, Pedevco has entered a critical operational phase. The market is now closely monitoring the...

For investors concerned about the volatility of traditional fixed-income markets, floating rate notes present a compelling alternative. The SPDR® Bloomberg...

Alpha Pro Tech's business model presents a study in strategic balance, navigating two distinct economic sectors. The company's performance is...

For shareholders of K+S (K&S DRC), the coming months are a period of anticipation. The agricultural inputs specialist is currently...

Roper Technologies has released its fourth-quarter 2025 financial results, presenting investors with a blend of outperformance and shortfall. The company's...

Nike Inc. is confronting a fresh challenge from U.S. regulators. The Equal Employment Opportunity Commission (EEOC) has initiated legal action...

Super Micro Computer delivered what appeared to be a blockbuster quarterly report on February 3rd, yet the market reaction was...

The year 2026 represents a critical period for Cellectar Biosciences as it advances its radiopharmaceutical pipeline toward key commercial and...